Center of Internal Medicine-Nephrology, Fundeni Clinical Institute, Sos. Fundeni 258, Bucharest, Romania.
J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8. doi: 10.1007/s11749-009-0177-3.
To evaluate the prevalence of HBV, HCV, HDV and HEV infections in populations with different categories of risk and the seroprevalence of HBV and HCV infections in subjects asking for a medical examination.
We conducted a cross-sectional, epidemiological study in 2,851 subjects from the SubCarpathian and South-Eastern Romania (including 17 counties, 34% of the country area and 42% of the population). The subjects were divided into four groups: controls (n=2,540, i.e. consecutive subjects asking for a medical examination), subjects with very low risk (students; n=44), with low risk (doctors and nurses; n=93) and with high risk for viral hepatitis (hemodialysis patients; n=174). All subjects were screened for HBsAg, antiHCV and ALT level. In populations at risk, antiHBs, HBeAg, antiHBe, antiHBc (IgG), HBV-DNA, HCV-RNA, antiHDV(IgG) and antiHEV(IgG) were also assessed.
In controls, HBV seroprevalence was 5.59% and HCV seroprevalence 4.56%. The risk factors for HBV infection were: age, male gender and South-East region of Romania. The risk factors for HCV infection were: age, female gender, elevated ALT level and the South-East region of Romania. In the very low risk population HBV, HCV, HDV and HEV seroprevalence was: 2.27%, 0%, 0% and 12.5%, respectively. In low risk population the seroprevalence was 2.15%, 1.07%, 0% and 13.98%. In hemodialysis patients, HBV and HCV seroprevalence were 7.91%, respectively 39.26%. HCV-RNA was detectable in 20.69% cases.
In the South and South-Eastern Romania the seroprevalence of viral hepatitis infections is intermediate, similar to other Romanian regions or the Balkans.
评估不同风险人群中乙型肝炎病毒(HBV)、丙型肝炎病毒(HCV)、丁型肝炎病毒(HDV)和戊型肝炎病毒(HEV)感染的流行率,以及要求体检者中HBV 和 HCV 感染的血清流行率。
我们在罗马尼亚东南部和南喀尔巴阡地区(包括 17 个县,占全国面积的 34%,占全国人口的 42%)的 2851 名受试者中进行了一项横断面、流行病学研究。这些受试者被分为四组:对照组(n=2540,即连续要求体检者)、低危组(学生;n=44)、低危组(医生和护士;n=93)和高危组(血液透析患者;n=174)。所有受试者均进行 HBsAg、抗 HCV 和 ALT 水平检测。在高危人群中,还评估了抗 HBs、HBeAg、抗 HBe、抗 HBc(IgG)、HBV-DNA、HCV-RNA、抗 HDV(IgG)和抗 HEV(IgG)。
在对照组中,HBV 血清流行率为 5.59%,HCV 血清流行率为 4.56%。HBV 感染的危险因素为:年龄、男性和罗马尼亚东南部。HCV 感染的危险因素为:年龄、女性、ALT 水平升高和罗马尼亚东南部。在低危人群中,HBV、HCV、HDV 和 HEV 的血清流行率分别为:2.27%、0%、0%和 12.5%。在低危人群中,血清流行率分别为 2.15%、1.07%、0%和 13.98%。在血液透析患者中,HBV 和 HCV 的血清流行率分别为 7.91%和 39.26%。HCV-RNA 可检测到 20.69%的病例。
在罗马尼亚南部和东南部,病毒性肝炎感染的血清流行率处于中等水平,与罗马尼亚其他地区或巴尔干地区相似。